Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Intellia Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 293
- +11 vs. Q3 2023
- Shares held
- 85.3M
- +5.16M (+6.4%) vs. Q3 2023
- Total value
- $2.60B
- +$66.1M (+2.6%) vs. Q3 2023
- New holders
- 47
- 123 more added
- Sold out
- 36
- 78 more reduced
4 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −17,569−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −15,950−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,295−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −14,241−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,280−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −11,862−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,960−100.0% | Sold out |
| Woodstock Corp | 0 | $0 | 0.00% | −9,002−100.0% | Sold out |
| Menard Financial Group LLC | 0 | $0 | 0.00% | −8,392−100.0% | Sold out |
| Steel Peak Wealth Management LLC | 0 | $0 | 0.00% | −8,308−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −7,810−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −7,638−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −7,185−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −6,528−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −6,273−100.0% | Sold out |
| Compagnie Lombard Odier SCmA | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Headinvest, LLC | 0 | $0 | 0.00% | −191−100.0% | Sold out |
| Grove Bank & Trust | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Key Financial Inc | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Northwest Investment Counselors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Atlas Venture Associates IX, LLC | – | – | – | – | Not filed |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |